NinjaXLightning Posted - 1 day ago

$HCP For recent reference, $ALPN accepted a $65 per share cash buyout from $VRTX a couple of weeks ago and has been trading at about $64.50 per share. Should see this trading over $34.

Aigner_Andreas Posted - 2 days ago

#TrendFollowing #TOP10 WK 17 BUY US $VST $AYX $NRG $ALPN $CAT RSG SLM WAB AXP SFM

intratio Posted - 2 days ago

$ALPN https://www.intratio.com/stock-forecast/ALPN The predictive algorithm is predicting that this stock s price will quickly deteriorate in the near future and has a dramatic negative long-term outlook

DiorCapital Posted - 6 days ago

$ALPN BIG BIG BIG GREEN CANDLE

hospitalphysician Posted - 1 week ago

@biotechdollars Personally, I feel a little ripped off on $ALPN. The price was a little low. Are you looking at anything else right now?. It is a tough market. I’m 80% cash, 10% long (9% is in one company) , and 10% short

krayzk4 Posted - 1 week ago

$ALPN if market has a big correction does this fall with it?

Aigner_Andreas Posted - 1 week ago

#TrendFollowing #TOP10 WK 16 BUY US $VST $EME $ALPN $NRG $WAB HIG SPOT TRV CAT THC

Blue_pineslapel Posted - 1 week ago

$ALPN why do I see big short coming🧐

RonIsWrong Posted - 1 week ago

$ALPN $XBI $MRUS $SWTX $FUSN FUSN ☑️ ALPN ☑️ SNDX _?_ SWTX - bring it !! KRYS _?_

Robbullishious Posted - 1 week ago

$VKTX the Effin market is relapsing the past few weeks.. MMs and retail taking profits.. It will re-correct itself soon.. Even $ALPN down after the 1st day back on the market after being bought out! That ought to tell you something is squirrelly with the market! On that note, ALPN is sitting where it needs to be at its current PP. however VKTX on the other hand is way to cheap for having the Best In Class Oral (Glp1/GIP) weight loss & top notch NASH/MASH upcoming drugs! We longs know what we have. The only thing holding the current PP down is the MM / bots as well as 18-24 months to FDA approval!

hospitalphysician Posted - 1 week ago

@LongInvestor2 Agreed. On the data alone, I think the stock could have hit $70. $ALPN was a big win for me, but I felt shortchanged.

AlertsAndNews Posted - 1 week ago

And that's a wrap for the week! Stellar plays on $PXMD $RLYB $ALPN $CADL $MGRM to name a few. Signing off on another productive week! Link in bio for more! All trading/investing involves a risk of loss. Do your own due diligence always!

knows_nothing Posted - 1 week ago

$ALPN is this call option a dud? Breakeven is 65.20 and exp is 11/15. But I don’t understand with the acquired news?

Capitulation_0 Posted - 1 week ago

$CYTK has 13.3% shorts.. that's 13.2m shares, rather high I'd say on the verge of a $13+B Buyout. $ALPN had 11.2% shorts. $CYTK shorts about to join $ALPN shorts on that pain ride.

erevnon Posted - 1 week ago

Leerink Partners downgrades Alpine Immune Sciences $ALPN from Outperform to Market Perform and raises the price target from $42 to https://marketsblock.com/stock-upgrades-and-downgrades/

FE123 Posted - 1 week ago

$JANX $ALPN Buyout offer can come on any Monday for $IOVA now that we are FDA Approved for Melanoma! $IOVA

Sakthi87 Posted - 1 week ago

$ALPN so what happens to the calls and puts booked on this stock? Looks like the price is going to stay the same per the below. “Alpine Immune Sciences, Inc. has agreed to be acquired by Vertex Pharmaceuticals Incorporated. Under the proposed transaction, Alpine shareholders will receive $65.00 per share.”

TheDayTradingAcademy Posted - 1 week ago

Alpine Immune Sciences shares based in Seattle, skyrocketed +36.90% on Thursday at $64.40, after Vertex Pharmaceuticals agreed to buy the biotech firm for $4.9B in cash. The deal values Alpine shares at $65, roughly 67% above its close on Tuesday, the day before reports that $ALPN was considering its options. Alpine stock is up +237.88% in 2024 & +780.98% y/y, with a market cap of $4.22B.

cholle Posted - 2 weeks ago

$ALPN +49.19%

Sakthi87 Posted - 2 weeks ago

$ALPN can someone please explain what will happen to calls and puts booked today on this stock? Looks like this stocks price is not going to move either way.

Iglorious18 Posted - 2 weeks ago

$IPA i feel like a hedge fund with just 4 shares moved the price up by 7.30% $ALPN

BioRich Posted - 2 weeks ago

$MLTX bought the news. This is a big deal and future is definitely north of 100$. My Scwab account shows $47.99 already. We may have a runner. Bios and BOs are hot right now. $ALPN $MRNA and $PFE bring that money over here for a nice 2x.

jitendermahajan Posted - 2 weeks ago

$ALPN so what happens next ? since they agreed to offer do I sell and move on ?

patatechaude Posted - 2 weeks ago

@Machman1 Tell that to the $ALPN long term holders. You hold and then it happens. $CAPR turn is coming.

CycleTrade Posted - 2 weeks ago

$ALPN oh boy

Alphasearch Posted - 2 weeks ago

$ALPN Congrats. Had this on my watch for months after showing up on a volume scan. Didn't pull the trigger due to it being a biotech, but should have given the last ER.

kokooo Posted - 2 weeks ago

$ALPN RIGL=3 approved drugs 120 million in revenue =and huge contract with LLY .good luck and stay safe.

Finnisher2M Posted - 2 weeks ago

$RLYB $ELYM $ALPN $RENT 👈👑 Crazy run

kokooo Posted - 2 weeks ago

$ALPN i believe they will pay around 1.5 to 2 billion for RIGL

kokooo Posted - 2 weeks ago

$ALPN for who asked me why i think lly will buy RIGL Lilly will pay an upfront cash payment to Rigel of $125 million. Rigel may also be eligible to receive up to $835 million in potential development, regulatory, and commercial milestone payments, as well as tiered royalties ranging from the mid-single digit to high-teens that will vary depending upon Rigel's clinical development investment. Lilly and Rigel will co-develop R552 at specified contribution levels. Lilly will be responsible for all costs of global commercialization for R552, and Rigel will have the right to co-commercialize R552 in the U.S. Lilly will be solely responsible for all clinical development and commercialization of brain penetrating RIPK1 inhibitors in CNS indications.